Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Erenumab (Aimovig®) | ||
 |
Eslicarbazepine tablets | ESCA. MHRA - Category 2 |
|
|
Esmolol injection | Hospital only |
|
|
Esomeprazole injection | Hospital use only |
|
|
Etamsylate | Hospital use only |
|
|
Ethinylestradiol tablets | 2micrograms and 10micrograms who cannot tolerate or are allergic to first-line patches |
|
|
Ethosuximide capsules | MHRA - Category 3 |
|
 |
Eurax hydrocortisone® cream | Mild steroid potency. Post-scabies once infection cleared but itch still present |
|
|
Everolimus (Afinitor®) |
|
Negative outcome - CDF funded for renal, NET, breast. For hospital use only. |
|
Everolimus (Votubia®) | As recommended by NHSE Refractory seizures associated with tuberous sclerosis |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- Next page
- Last page
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
